Fresh Rounds

Aprea Therapeutics, Inc. funding

Aprea Therapeutics, Inc., a biotechnology company based in Doylestown, PA, filed a Form D with the SEC on December 29, 2025 and reported $3.1M raised of a $5.8M offering.

Amount raised$3.1M
Offering size$5.8M
Filed with the SECDecember 29, 2025
First saleDecember 10, 2025
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationDoylestown, PA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far8
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Pennsylvania